Tag Archives: SCOTUS

Mutual v. Bartlett: A Line in the Sand on Side Effects

The Supreme Court ruled last Monday in the case of Mutual Pharmaceuticals v. Bartlett that generic drug makers cannot change labeling or the formula of a drug after it has been approved by the FDA. The majority, which included Justices Alito, Roberts, Scalia, Kennedy, and Thomas, concluded that federal regulation trumps state tort liability law, […]
Posted in FDA, Legal, Market Access, Marketing, Regulatory, Safety | Also tagged , , , , , , , , , , , , , , , , | Leave a comment

HCR and the Supreme Court: Three Important Days in March

The Supreme Court will open up deliberations on the constitutionality of three important parts of healthcare reform (HCR) this month. by Tom Norton After nearly two years of legal wrangling, on November 14, 2011 the Supreme Court (SCOTUS) determined that as a result of contradictory US Appellate Courts findings on the Patient Protection and Affordable […]
Posted in healthcare, Legal, Strategy | Also tagged , , , | Leave a comment
  • Categories

  • Meta